Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) Gross Margin (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Gross Margin for 16 consecutive years, with 53.4% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin fell 1586.0% to 53.4% in Q4 2025 year-over-year; TTM through Dec 2025 was 68.08%, a 55.0% decrease, with the full-year FY2025 number at 71.53%, up 290.0% from a year prior.
  • Gross Margin was 53.4% for Q4 2025 at Lemaitre Vascular, down from 80.47% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 80.47% in Q3 2025 to a low of 53.4% in Q4 2025.
  • A 5-year average of 66.62% and a median of 65.92% in 2021 define the central range for Gross Margin.
  • Biggest YoY gain for Gross Margin was 1265bps in 2025; the steepest drop was -1586bps in 2025.
  • Lemaitre Vascular's Gross Margin stood at 65.71% in 2021, then fell by -3bps to 63.62% in 2022, then rose by 7bps to 68.05% in 2023, then grew by 2bps to 69.26% in 2024, then dropped by -23bps to 53.4% in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Gross Margin are 53.4% (Q4 2025), 80.47% (Q3 2025), and 70.02% (Q2 2025).